(Q33340910)

25 July 2017

title

PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma (English)

1 reference

metastatic prostate carcinoma

25 July 2017

1 reference

1 reference

Rajni Sharma

3

0 references

Fabio Tavora

series ordinal

2

object named as

Fabio Tavora

1 reference

25 July 2017

Wenle Wang

1

1 reference

25 July 2017

Mario Eisenberger

series ordinal

4

1 reference

25 July 2017

George J Netto

series ordinal

5

1 reference

25 July 2017

publication date

4 June 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

27

1 reference

25 July 2017

issue

5

1 reference

25 July 2017

page(s)

525-528

1 reference

Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Molecular imaging in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Clinical utility of radiolabeled monoclonal antibodies in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Technology insight: monoclonal antibody imaging of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Expression of prostate-specific membrane antigen in normal and malignant human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Expression analysis of ?-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

Expression of glutamate carboxypeptidase II in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.007

10.1016/J.UROLONC.2008.04.007

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference